Premium
Cytogenetic and Molecular gene array analyses of radiation‐induced meningiomas
Author(s) -
KleinschmidtDeMasters Bette K.,
Donson Andrew M,
Foreman Nicholas K,
Lillehei Kevin O
Publication year - 2007
Publication title -
the faseb journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.709
H-Index - 277
eISSN - 1530-6860
pISSN - 0892-6638
DOI - 10.1096/fasebj.21.5.a388-c
Subject(s) - monosomy , radiation therapy , radiosurgery , sarcoma , microarray , chromosome , meningioma , cancer research , medicine , microarray analysis techniques , biology , chemotherapy , gene , oncology , pathology , radiology , genetics , karyotype , gene expression
We studied 20 radiation‐induced meningiomas RIMs seen since 1993 for cytogenetic alterations and clinical outcome. Most were WHO grade I tumors. Abnormalities of chromosome 1p and/or LOH 1p36 was identified in 5 of 11 informative cases, with monosomy 22 in 4. Most could be managed surgically, either with a single extensive resection or with re‐resection. Several have shown no growth and have required no neurosurgical intervention. Stereotactic radiosurgery or radiation + chemotherapy have been used selectively (6). Affymetrix gene array study in 2 examples were compared to a large number of other tumors (n=52) and showed that RIMs clustered closely with radiation‐induced sarcoma and Ewing's sarcoma, but not with radiation‐induced glioblastomas. RIMs generally have a favorable prognosis, although therapy needs to be individually tailored. Gene microarray illustrates a more distinctive “signature” for RIMs than does cytogenetic analysis.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom